FDA clears Smiths Medical's at-home ambulatory care unit

February 14, 2013 by MassDevice staff

The FDA gives Smiths Medical the OK to launch its Cadd-Solis ambulatory care system in the U.S.

Smiths Medical logo

St. Paul, Minn,-based device maker Smiths Medical got the green-light from the FDA for its newest ambulatory infusion system, which has been approved for at-home use.

The Cadd-Solis VIP ambulatory infusion system integrates some of Smith Medical's other products, including its infusion pump, medication-level monitoring system and medication reservoirs

Sign up to get our free newsletters delivered right to your inbox.

"The new Cadd-Solis VIP system provides enhanced safety features and convenience for healthcare providers who want to provide optimal care for their infusion patients in the home," CEO Srini Seshadri said in a press release.

Earlier this month, MassDevice.com reported that Smiths Medical sold 23 U.S. patents to Tandem Diabetes Care. That sale included the licenses for all future product development in ambulatory infusion pumps and all related accessories and software, according to a statement by Tandem Diabetes Care.